INTRODUCTION

I
n vitro Lymphocyte's stimulation methods are extensively used for expansion of these cells, adoptive immunotherapy of cancer and study of their function [1, 2] . PHA as a mitogenic molecule and monoclonal antibodies yield polyclonal proliferation whereas specifi c antigen promotes a monoclonal or oligoclonal response. PHA activates lymphocytes through binding to cell membrane glycoproteins such as the T-cell receptor (TCR)-CD3 complex. There are a number of mitogenic antibodies containing those engaged towards the TCR, CD2, CD3 and CD28 molecule [1] . Specifi c antibodies against TCR-CD3 complex provide an initial activation signal, but proliferation is dependent on a co-stimulatory signal, mostly provided by means of the CD28 molecule [1, [3] [4] [5] . These antibodies are often bound to accessory cells, beads, or a solid surface to mimic professional APCs [1, 6] because free antibodies usually provide insuffi cient cross-linking of the receptor to activate intracellular signaling cascades [1] .
With success of T cells manipulation and stimulation methods [4] such as PHA, autologous antigen presenting cells with specifi c peptide, and anti-CD3 and anti-CD28-coated beads [7] , it is possible to stimulate and expand lymphocytes to adoptive transfer [4, 7] . Nowadays, adoptive transfer of T cells is known successful treatment for infections and cancer such as HIV infection and multiple myeloma [3, [8] [9] [10] . For adoptive transferring of T lymphocyte, a large number of cells are required, and on the other hand, effi ciently, adoptive transfer need an antigenspecifi c T cell obtaining from blood or tissue sites, but the obtained cells are not suffi cient [4] . The abovementioned methods were usually used to effi ciently expand these cells for the next investigation [11] . The aim of this study is to defi ne proliferation ability of two different stimulators on CD4+ lymphocytes.
OBJECTIVES
PHA and anti-CD2/CD3/CD28 MACSiBead™ were used to defi ne which of them cause more proliferated-CD4+ lymphocytes.
MATERIALS AND METHODS
Isolation of lymphocytes from peripheral blood
Three healthy individuals were enrolled in this study. Freshly peripheral blood samples were collected from the healthy donors under written informed consent. Peripheral blood mononuclear cells (PBMCs) were separated using Ficoll-Paque density gradient centrifugation (Biowest, France). To prepare lymphocytes for selected experiments, PBMCs were incubated in a cell culture fl ask in 5% CO2 incubator in order to remove adherent cells (monocytes). Lymphocytes were isolated from PBMCs after removing adherent cells (monocytes) then CD4+ T lymphocytes were isolated and expanded as described below.
CD4+ T lymphocytes isolation & Culture
CD4+ cells were enriched with an isolation kit containing a cocktail of CD8, CD14, CD16, CD19, CD36, CD56, CD123, TCR, and CD235a (glycophorin A) (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany). Then, CD4+ cells were purifi ed using APC labeled anti-CD4 antibodies (Ebioscience, USA). The purity of isolated CD4+ T lymphocytes was above 87% based on CD4 expression as assessed by fl ow cytometry. The CD4+ T lymphocytes were labeled with carboxyfl uorescein diacetate succinimidyl ester (CFSE) (Invitrogen, Life Technologies, Carlsbad, CA), which is used to examine cells division and expansion after stimulation. Briefl y, to label cells, 1 × 10 6 lymphocytes maintained in RPMI 1640 containing 10% fetal calf serum (RPMI/FCS) were incubated with 2 M CFSE at 37°C for 10 min. Lymphocytes were then washed two times to remove unbound CFSE, resuspended in a fresh medium. The CFSE-labeled cells were cultured in RPMI-1640 medium (Gibco, USA) containing 10% fetal calf serum (Biosera, France), 100 U/mL penicillin/100 g/ mL streptomycin (Gibco, USA), 2 mm l-glutamine (Gibco, USA), 1 mm sodium pyruvate (Gibco, USA) supplemented with PHA (Gibco, USA) or anti-CD2/ CD3/CD28 MACSiBead™ (Miltenyi Biotech, Germany). Labeled cells were then distributed (100,000/ well) in a 96 well round bottom plate in the presence of anti-CD2/CD3/CD28 MACSiBead™ (three beads/ cell), PHA or no additional stimulator and were fed with the further fresh medium at day 3.
Monitoring CD4+ lymphocyte cells division and expansion using CFSE
The expansion after stimulation was analyzed using methods described following. Cells were analyzed on FACSCalibur fl ow cytometry (Becton Dickinson, USA) at day 5. The proportion of CD4+ gated lymphocytes undergoing 0-6 divisions then were quantitated based on the pattern of CFSE fl uorescence using Flow-Jo software.
Statistical analysis
The data were analyzed by the Mann-Whitney U test with the use of GraphPad Prism software for Windows (GraphPad Software, La Jolla, CA, USA). Data were presented as means ± SD. Differences were considered signifi cant at p value < 0.05.
RESULTS
To determine the effect of anti-CD2/CD3/CD28 MACSiBead™ and PHA on the expansion and proliferation ability of human CD4+ T lymphocytes, we cultured isolated Lymphocytes from healthy individuals in different conditions. First, 1 × 10 6 CFSE labeled lymphocytes were cultured and stimulated with anti-CD2/CD3/CD28 MACSiBead™ and PHA. To set the undivided peak fl uorescence, CFSE labeled lymphocytes were also cultured in the absence of any stimulators (untreated CD4+ lymphocytes in fi g-ures). Lymphocytes were harvested and stained for CD4 marker, and then analyzed for CFSE using fl ow cytometry. A CFSE division profi le of anti-CD2/CD3/ CD28 MACSiBead™ and PHA stimulated CD4+ lymphocyte during six days are illustrated in following fi gures (fi g. 1 A, B, C). Up to fi ve or six separate division cycles could be visualized by different CFSE signal peaks. More cell divisions were diffi cult to determine as peaks tended to be compact.
As shown in fi gure 1, the results indicate a difference in the proliferation ability of PHA and anti-CD2/CD3/ CD28 MACSiBead™, although each of these stimulus methods resulted in extensive CD4+ lymphocyte proliferation. The Proliferation of CD4+ lymphocytes stimulated by PHA showed an increase when compared with the cells stimulated by anti-CD2/CD3/ CD28 MACSiBead™. The proliferation rate of cells stimulated by PHA was 93.8% ± 3.37%, whereas it was 85.2% ± 4.7% in cells stimulated by anti-CD2/ CD3/CD28 MACSiBead™s. There was no signifi cant difference in the proliferation ability of PHA and anti-CD2/CD3/CD28 MACSiBead™ (p value = 0.1). 
DISCUSSION
Antigen-specifi c CD4+ T lymphocytes are produced by adding repeated cycles of the stimulating antigen with autologous antigen-presenting cells and IL-2. We can reduce the requirement for large amounts of specifi c antigen by adding anti-CD2/CD3/CD28 MACSiBead™ after the primary antigen stimulation, without loss of antigen specifi city [1] .
As the adoptive transfer of autologous T cells is useful for patients with infections and cancer [3, 8] , we analyzed proliferation ability of the two methods including anti-CD3, anti-CD2, anti-CD28-coated beads, and PHA. Many studies used anti-CD3/CD28 coated beads but not anti-CD3, anti-CD2 and anti-CD28-coated beads to expand T cells [1, 3, 8, 12 ]. In the current study, in addition to anti-CD3/CD28, anti-CD2 was used in order to increase the signals received by T cells which improve the stimulation and enhance the proliferation of T cells. Our results indicated that the proliferation ability of the PHA method was higher than anti-CD3, anti-CD2, and anti-CD28-coated beads method. However, with considering the rate of proliferation ability of MACSiBead™ and PHA which was 85.2% and 93.8%, respectively, it can be said that MACSiBead™ along with PHA provides a simple, fast and reproducible method for polyclonal T cell stimulation and yield a large number of expanded CD4+ lymphocytes.
Conclusion:
Finally, expanded T cells can be used in T cell functional assays either directly after stimulation or after extensive proliferation [1] . In addition, T cells can be manipulated to improve their specifi city and increase their robust responsiveness for the next investigations.
